ENDRA Life Sciences Inc. — Director's Dealing 2022

Mar 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2022-03-28

Reporting Person: DIGIANDOMENICO ANTHONY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-28	Stock Options	$0.38	A	109323	Acquired	2032-03-28	Common Stock (109323)	Direct

Footnotes

F1: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023.